based upon advanced diagnostics.
HIFU Focal Therapy: Precision Prostate Cancer Treatment
“In Focal Therapy, the aim is to get rid of the cancer that is causing concern whilst ensuring that the patient does not become incontinent and has a much lower chance of losing erectile function.”
Mr Tim Dudderidge, Urological Consultant at The Focal Therapy Clinic
WHAT IS HIFU FOCAL THERAPY
FOR PROSTATE CANCER?
Focal Therapy is a general term for a minimally invasive treatment for prostate cancer, targeting only the area of the prostate gland with the aggressive tumour while leaving the rest of the prostate and its surrounding structures alone.
High Intensity Focused Ultrasound (HIFU) is the most popular and well-evidenced type of Focal Therapy treatment for prostate cancer. Extensive clinical trials have shown that HIFU provides effective cancer control whilst minimising risks of erectile dysfunction and urinary continence.
HIFU is a soundwave-based treatment for prostate cancer that uses a pair of high-energy ultrasound beams that heat targeted areas of the prostate, destroying cancer cells.
HIFU is done under precise image guidance, making it highly targeted. This means it avoids damaging areas that control urinary and erectile functions.
HIFU is performed under general anaesthetic in a single treatment session. Usually lasting between 90 and 140 minutes, it is a largely well-tolerated procedure that allows men to leave the hospital within 90 minutes of completion.
The majority of men resume normal activity within 2 – 4 days although strenuous exercise is not recommended in the first week after treatment.
The Focal Therapy Clinic network of expert urological consultants have been pioneering the development and use of HIFU in the UK for over 15 years. We use the most advanced equipment and expertise to ensure safe and accurate HIFU treatment, quicker recovery and better results.
“Using precision diagnostics, we are able to pinpoint and treat the specific area of cancer. Traditional prostate cancer treatment is like using a sledgehammer to kill a flea.”
Alan Doherty, Urological Consultant at The Focal Therapy Clinic
BENEFITS OF HIFU FOCAL THERAPY
- Effective cancer control – similar to radical prostatectomy or radiotherapy treatments
- Minimally invasive (no surgery, no radiation, no hormone therapy)
- Day (outpatient) procedure
- Quick recovery time (within 2-3 days)
- Minimal pain and discomfort
- Minimal risk of incontinence (98% fully continent at 2 weeks)
- Preservation of erectile function (95% maintain erectile function)
- Can be repeated if necessary
- Does not exclude further treatment with radiotherapy or surgery
Listen to Consultant Urologist Tim Dudderidge provides a clinical overview of focal therapy
"In delivering the treatment we avoid the patient having progressive disease, but, importantly, we preserve their functional status, meaning the patient does not become incontinent and has a lower chance of losing erectile function."
request a callback
At The Focal Therapy Clinic we are passionate about prostate cancer sufferers knowing about all of their treatment options.
We know that settling on the right treatment is a big decision for you. If you would like to speak to one of our friendly and knowledgeable patient advocates about your diagnosis and the HIFU Focal Therapy treatment option then please do not hesitate to get in touch today.
All enquiries to The Focal Therapy Clinic are confidential, and we are delighted to offer our advice and support with no obligation.
HIFU FOCAL THERAPY PROCEDURE
FOCAL THERAPY FOR
RECURRENT PROSTATE CANCER
The development of salvage focal therapy has been transformative for men who have had a recurrence of clinically significant prostate cancer following radiotherapy treatment. It offers these men a chance to cure, or to prevent the progression of, their cancer – and to avoid further invasive treatment and long-term hormone therapy.
Two of our consultants, Mr Tim Dudderidge and Mr Raj Nigam, have been pioneering focal salvage treatments over many years. They have both participated in major clinical trials that have established the value of Focal Therapy as a salvage treatment for patients with recurrent prostate cancer following Radiotherapy.